S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7120 +0.15%
AFTER HRS · 18:15 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead
AF
INSIDER · ARTV · Artiva Biotherapeutics, Inc. · CHIEF EXECUTIVE OFFICER

Aslan Fred

Every open-market transaction filed under this name, Sep 3 to Oct 6.

Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$1.5M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 6ARTVArtiva Biotherapeutics, Inc.Chief Executive OfficerSell23,463$7.20$169K−17.9%
Oct 5ARTVArtiva Biotherapeutics, Inc.Chief Executive OfficerSell61,696$6.84$422K−13.6%
Sep 8ARTVArtiva Biotherapeutics, Inc.Chief Executive OfficerSell23,429$10.92$256K−45.9%
Sep 3ARTVArtiva Biotherapeutics, Inc.Chief Executive OfficerSell61,888$11.16$690K−47.0%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.